Prescription for e-Sourcing

GlaxoSmithKline chooses Emptoris global strategic sourcing

Burlington, MA  September 5, 2002  Emptoris Inc., a provider of collaborative strategic sourcing solutions, this week announced that GlaxoSmithKline has selected Emptoris' ePASS as the sourcing platform for its global strategic sourcing initiatives. Under the terms of the agreement, GlaxoSmithKline will implement ePASS, a portfolio of collaborative sourcing solutions, across the enterprise, including the United States, United Kingdom and other major European and international countries.

By implementing ePASS, Emptoris said GlaxoSmithKline is going to be able to perform its global strategic sourcing processes  including supplier qualification, RFx management, reverse auctions, and multi-stage, Internet-based negotiations  online. Through optimization-based decision support technology, Sourcing Group Managers from GlaxoSmithKline's business sectors can analyze purchasing scenarios using scientific algorithms to determine the optimal supply-base allocation. The combination of auction, quoting, data management and decision support capabilities will enable GlaxoSmithKline to lower purchased goods and service costs, improve supplier performance and achieve faster cycle times.

"Each business unit of GlaxoSmithKline has unique, complex decision factors that need to be taken into account when making sourcing decisions," said R. Gregg Brandyberry, director global systems and processes, GlaxoSmithKline Procurement. "We evaluated twelve sourcing solutions and chose ePASS because it was clearly the market leader in terms of the functionality required to take us to the next level in sourcing."

"We're on a mission to be the best procurement organization regardless of industry," commented Willie Deese, Sr. vice president, GlaxoSmithKline procurement. "The breadth and depth of the Emptoris solution will allow us to bring more spend categories online quicker, thus driving a faster return on investment."

Avner Schneur, president and CEO of Emptoris added: "The pharmaceutical industry is yet another market that can greatly benefit from advanced e-sourcing solutions to enable the sourcing of complex goods and services online." He said that GlaxoSmithKline has gained a reputation as a company that uses technology to automate and optimize a number of its business processes, and by implementing ePASS, it will be able to improve its bottom line.